Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71701 - 71725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	MROH1	727957	upregulated	Silicon Dioxide analog results in increased expression of MROH1 mRNA	8q24.3	A24195
Silicon dioxide	Approved	MROH6	642475	upregulated	Silicon Dioxide analog results in increased expression of MROH6 mRNA	8q24.3	A24195
Silicon dioxide	Approved	MROH7	374977	downregulated	Silicon Dioxide analog results in decreased expression of MROH7 mRNA	1p32.3	A24195
Silicon dioxide	Approved	MROH8	140699	downregulated	Silicon Dioxide analog results in decreased expression of MROH8 mRNA	20q11.23	A24195
Silicon dioxide	Approved	MRPL1	65008	upregulated	Silicon Dioxide analog results in increased expression of MRPL1 mRNA	4q21.1	A24195
Silicon dioxide	Approved	MRPL12	6182	upregulated	Silicon Dioxide analog results in increased expression of MRPL12 mRNA	17q25.3	A24195
Silicon dioxide	Approved	MRPL20	55052	downregulated	Silicon Dioxide results in decreased expression of MRPL20 mRNA	1p36.33	A24196
Silicon dioxide	Approved	MRPS30	10884	upregulated	Silicon Dioxide analog results in increased expression of MRPS30 mRNA	5p12	A24195
Silicon dioxide	Approved	MSANTD2	79684	upregulated	Silicon Dioxide analog results in increased expression of MSANTD2 mRNA	11q24.2	A24195
Silicon dioxide	Approved	MSMB	4477	downregulated	Silicon Dioxide analog results in decreased expression of MSMB mRNA	10q11.22	A24195
Silicon dioxide	Approved	MSMO1	6307	upregulated	Silicon Dioxide analog results in increased expression of MSMO1 mRNA	4q32.3	A24195
Silicon dioxide	Approved	MSRB2	22921	downregulated	Silicon Dioxide analog results in decreased expression of MSRB2 mRNA	10p12.2	A24195
Silicon dioxide	Approved	MST1	4485	downregulated	Silicon Dioxide analog results in decreased expression of MST1 mRNA	3p21.31	A24195
Silicon dioxide	Approved	MSX2	4488	upregulated	Silicon Dioxide analog results in increased expression of MSX2 mRNA	5q35.2	A24194
Silicon dioxide	Approved	MSX2P1	55545	upregulated	Silicon Dioxide analog results in increased expression of MSX2P1 mRNA	17q23.2	A24194
Silicon dioxide	Approved	MT1B	4490	downregulated	Silicon Dioxide analog results in decreased expression of MT1B mRNA	16q13	A24194
Silicon dioxide	Approved	MT1E	4493	downregulated	Silicon Dioxide analog results in decreased expression of MT1E mRNA	16q13	A24195
Silicon dioxide	Approved	MT1F	4494	downregulated	Silicon Dioxide analog results in decreased expression of MT1F mRNA	16q13	A24195
Silicon dioxide	Approved	MT1G	4495	downregulated	Silicon Dioxide analog results in decreased expression of MT1G mRNA	16q13	A24194
Silicon dioxide	Approved	MT1H	4496	downregulated	Silicon Dioxide analog results in decreased expression of MT1H mRNA	16q13	A24194
Silicon dioxide	Approved	MT1L	4500	downregulated	Silicon Dioxide analog results in decreased expression of MT1L mRNA	16q13	A24194
Silicon dioxide	Approved	MT1L	4500	upregulated	Silicon Dioxide analog results in increased expression of MT1L mRNA	16q13	A24195
Silicon dioxide	Approved	MT1M	4499	downregulated	Silicon Dioxide analog results in decreased expression of MT1M mRNA	16q13	A24194
Silicon dioxide	Approved	MT1X	4501	downregulated	Silicon Dioxide analog results in decreased expression of MT1X mRNA	16q13	A24194
Silicon dioxide	Approved	MT3	4504	downregulated	Silicon Dioxide analog results in decreased expression of MT3 mRNA	16q13	A24194

Displaying entries 71701 - 71725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability